Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the ...

We recently published an article titled These 10 Stocks Moved the Market This Week, Here’s Why. In this article, we are going ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...